logo-loader

Proactive news round-up: Amryt Pharma, Minds+Machines, Aminex ...

Published: 16:50 05 Dec 2016 GMT

picture of newspapers

Ambitious Amryt Pharma PLC (LON:AMYT) has unveiled its second major deal in three days as it outlined plans to in-licence a cash-generative cholesterol drug.

On Friday, the company, whose portfolio is focused on rare or orphan diseases, told investors it had tied up a €20mln European Investment Bank loan facility to fund the late stage development of its lead drug.

Monday’s agreement with NASDAQ-listed Aegerion Pharmaceuticals brings into the portfolio the product LOJUXTA, known generically as lomitapide

Minds + Machines Ltd (LON:MMX) said it has received the green light from the Chinese authorities for its .vip top level domain.

Registrations for the .vip top level domain have now passed 500,000 registrations in China, so official approval from China’s Ministry of Industry and Information Technology (MIIT) for the top level domain (TLD) – the bit in an internet address after the final dot – is a fairly big deal for the company.

Armadale PLC’s (LON:ACP) new partner has decided to push ahead with the development of the Mpokoto gold mine in the DRC.

Kissenge Mining (KMP), formerly known as African Mining Services, has completed due diligence and will now start work on a phase one programme.

Aminex plc (LON:AEX) told investors drilling will get underway soon for the Ntorya-2 appraisal well in Tanzania.

It confirmed today that an independent inspection of the contracted drill rig has now been completed and the project is scheduled to start in mid-December.

Pan African Resources plc (LON:PAF) is to build a new tailings plant at Elikhulu after a definitive feasibility study confirmed it was viable.

Elikhulu will be built on the site of the existing Evander mine.

In its bid to become the go-to security systems manufacturer, Newmark Security PLC (LON:NWT) has unveiled its latest products to the market.

Under its Grosvenor Technology brand, Newmark has launched its Sateon Advance access control system as well as an Android-based terminal for workforce management called GT-10.

ReNeuron Group Plc (LON:RENE) has delivered encouraging results from its phase II clinical study treating stroke patients with its CTX stem cells.

The PISCES II trial, led by professor Keith Muir of Glasgow University, monitored improvement in arm movement as measured by the ARAT sub-test number two.

Mining company investor Metal Tiger PLC (LON:MTR) has undergone its second major boardroom overhaul in the space of two months.

Chief executive Alex Borelli has resigned having taken up the post on 17 October. Also departing are chairman Terry Grammer and technical director Jordan Luckett.

Tertiary Minerals plc (LON:TYM) has disposed of two gold leases in Finland to Canada-listed group Aurion Resoruces (CVE:AU).

The miner will keep a royalty interest in the two sites, Kaaresselkä and Kiekerömaa, and receive US$100,000 in cash and shares.

Oriole Resources outlines 2023 achievements and future exploration plans

Oriole Resources PLC (AIM:ORR) CEO Tim Livesey and chief financial officer Bob Smeeton join Proactive's Stephen Gunnion with details of the company's 2023 financial and operational performance. Livesey highlighted successful exploration programs in Cameroon, at the Bibemi and Mbe projects,...

36 minutes ago